Skip to main content
. 2026 Oct 26;18(21):3453. doi: 10.3390/cancers18213453
4-HNE 4-hydroxy-2-nonenal
AAPC Average annual percentage change
ADC Adenocarcinoma
AKT Protein kinase B
APC Annual percentage change
ARIMA Autoregressive integrated moving average
ASIR Age-standardised incidence rate
ASR Age-standardised rate
BAPC Bayesian age–period–cohort
BMI Body mass index
BRICS Brazil, Russia, India, China and South Africa
CI Confidence interval
CIMP CpG island methylator phenotype
CISNET Cancer Intervention and Surveillance Modeling Network
CRC Colorectal cancer
DALY Disability-adjusted life year
DASH Dietary Approaches to Stop Hypertension
EOCRC Early-onset colorectal cancer
ERK Extracellular signal-regulated kinase
FIT Faecal immunochemical test
GBD Global Burden of Disease
GLOBOCAN Global Cancer Observatory estimates of cancer incidence and mortality
HDI Human Development Index
HR Hazard ratio
IBD Inflammatory bowel disease
IGF-1 Insulin-like growth factor 1
IL-6 Interleukin 6
IRR Incidence rate ratio
LRAU Long-term or recurrent antibiotic use
MAPK Mitogen-activated protein kinase
MDA Malondialdehyde
MMP Matrix metalloproteinase
MP Microplastic
mTOR Mechanistic target of rapamycin
NEN Neuroendocrine neoplasm
NF-κB Nuclear factor kappa B
OR Odds ratio
PFAS Per- and polyfluoroalkyl substances
PFOA Perfluorooctanoic acid
PFOS Perfluorooctane sulfonate
PI3K Phosphoinositide 3-kinase
PKC Protein kinase C
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PSC Primary sclerosing cholangitis
RR Relative risk
SDI Socio-demographic Index
TMAO Trimethylamine N-oxide
TNF-α Tumour necrosis factor alpha
UPF Ultra-processed food